Product Program year 2025 Source: CMS Open Payments

CellFX

Device Interventional Radiology

PDI 00850003231389

Open in the dashboard

General payments

$1,871,166

305 payments

Research payments

$303,000

6 payments

Through program year 2025, $1,871,166 in general payments and $303,000 in research payments were reported against CellFX (Interventional Radiology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $1,714,518 276
2025 Research $303,000 6
2024 General $156,648 29

Breakdown

Who paid General payments · program years 2024–2025
  1. Pulse Biosciences, Inc. $1,871,166 305 payments
Top recipients General payments · program year 2025
  1. Niv Ad Takoma Park, MD $475,097 28% · 32 payments
  2. Gansevoort Dunnington Interventional Cardiology · Richmond, VA $440,132 26% · 34 payments
  3. Ralph Tufano Otolaryngology · Sarasota, FL $272,484 16% · 41 payments
  4. Emad Kandil Surgery · Owings Mills, MD $159,036 9% · 20 payments
  5. Alireza Falahati-Nini Endocrinology, Diabetes & Metabolism · Salt Lake City, UT $84,556 5% · 22 payments

The top 5 of 70 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $440,132 36% · 1 practitioner
  2. Surgery $335,812 27% · 15 practitioners
  3. Otolaryngology $294,024 24% · 9 practitioners
  4. Endocrinology, Diabetes & Metabolism Internal Medicine $85,576 7% · 9 practitioners
  5. Surgical Oncology Surgery $58,304 5% · 2 practitioners

The top 5 of 19 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Maryland $634,133 37% · 2 recipients
  2. Virginia $440,267 26% · 2 recipients
  3. Florida $275,936 16% · 9 recipients
  4. New York $165,998 10% · 10 recipients
  5. Utah $84,939 5% · 4 recipients

The top 5 of 21 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

305 general · 6 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record